Daily Yonder Explores Impacts of Rural Pharmacy Closures

Sep 13, 2022 - Highlights trends in rural pharmacy closures and the impacts of closures on rural communities, including access to health services and medication. Breaks down differences in pharmacy closures for rural and urban areas, and notes financial challenges contributing to closures.

view details

HHS: Declaration That Circumstances Exist Justifying Authorizations Pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (Monkeypox) Federal Register

Sep 13, 2022 - Notice from the U.S. Department of Health and Human Services (HHS) announcing that the Secretary of HHS determined that there is a public health emergency, or a significant potential for a public health emergency, that involves the monkeypox virus on August 9, 2022. On this basis, the Secretary declared that circumstances exist justifying authorizations of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus on September 7, 2022.

view details

HHS: Publication of OIG Special Fraud Alerts Federal Register

Aug 23, 2022 - Notice from the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) announcing two Special Fraud Alerts previously published by OIG on its website. The Special Fraud Alerts cover 1) the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to speaker programs by pharmaceutical and medical device companies and 2) fraud schemes involving companies that purported to provide telehealth, telemedicine, or telemarketing services and exploited the growing acceptance and use of telehealth.

view details

CMS: Medicare and Medicaid Programs; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicare and Medicaid Provider Enrollment Policies, Including for Skilled Nursing Facilities; Conditions of Payment for Suppliers of Durable Medicaid Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); and Implementing Requirements for Manufacturers of Certain Single-Dose Container or Single-Use Package Drugs To Provide Refunds With Respect to Discarded Amounts Federal Register

Jul 29, 2022 - Notice of proposed rule from the Centers for Medicare & Medicaid Services (CMS) making changes to the following: 1) Physician Fee Schedule and Medicare Part B payment policies; 2) Medicare Shared Savings Program requirements; 3) updates to the Quality Payment Program; 4) Medicare coverage of opioid use disorder services furnished by opioid treatment programs; 5) updates to certain Medicare and Medicaid provider enrollment policies; 6) updates to conditions of payment for DMEPOS suppliers; 7) coding and payment for wound care management product; and 8) requirements for electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or an MA-PD plan. Includes rural references throughout. Comments on the proposed rule are due by September 6, 2022.

view details